Conduction system disease in fetuses evaluated for irregular cardiac rhythm

Fetal Diagnosis and Therapy

Volumn 21, Issue 3, 2006, Pages 307-313

  Cuneo, Bettina F ^a   Strasburger, Janette F ^b   Wakai, Ronald T ^c   Ovadia, Marc ^a,d  

^a RUSH MEDICAL COLLEGE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Arrhythmia; Echocardiography; Fetal magnetocardiography; Heart block

Indexed keywords

DEXAMETHASONE; LA ANTIBODY; RO ANTIBODY;

ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; IDIOPATHIC DISEASE; M MODE ECHOCARDIOGRAPHY; MAGNETOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PR INTERVAL; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; QT PROLONGATION; RETROSPECTIVE STUDY; REVIEW;

ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ARRHYTHMIA; AUTOANTIGENS; ECHOCARDIOGRAPHY; FEMALE; FETAL DISEASES; HEART BLOCK; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS;

EID: 33645659535     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091362     Document Type: Review

References (24)

1. Strasburger JF, Huhta JL, Carpenter RJ, et al: Doppler echocardiography in the diagnosis and management of persistent fetal arrhythmias. J Am Coll Cardiol 1986:7:1386-1391.
2. Glickstein JS, Buyon J, Friedman D: Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000:86:236-239.
3. Silverman NH, Enderlein MA, Stanger P, Teitel DF, et al: Recognition of fetal arrhythmias by echocardiography. J Clin Ultrasound 1985;13:255-263.
4. Fyfe DA, Meyer KB, Case Cl: Sonographic assessment of fetal cardiac arrhythmias. Semin Ultrasound CT MR 1993;14:286-297.
5. Andelfinger G, Fouron JC, Sonesson SE, Proulx F: Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 2001:88:1433-1436.
6. Kleinman CS: Prenatal diagnosis and management of intrauterine arrhythmia. Fetal Ther 1986:1:92-95.
7. Reed Kl: Fetal arrhythmias, etiology, diagnosis, pathophysiology and treatment. Semin Perinatol 1989;13:294-304.
8. Buyon JP, Hiebert R, Copel J, et al: Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national lupus registry. J Am Coll Cardiol 1998;31:1658-1666.
9. Hofbeck M, Ulmer H, Beinder E, et al: Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart 1997;77:198-204.
10. Saleeb S, Copel J, Friedman D, Buyon JP: Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Arthritis Rheum 1999;42:2335-2345.
11. Buyon JP, Waltuck J, Kleinman C, et al: In utero identification and therapy of congenital heart block (CHB). Lupus 1995;4:116-121.
12. Cuneo B, Ovadia M, Strasburger J, et al: Prenatal diagnosis and in utero treatment of torsades des pointes associated with congenital long QT syndrome. Am J Cardiol 2003;9:1395-1398.
13. Rosenthal D, Friedman DM, Buyon J, Dubin A: Validation of the Doppler PR interval in the fetus. J Am Soc Echocardiogr 2002;15:1029-1030.
14. Davignon A, Rautaharju PM, Boisselle E, et al: Normal 12-lead ECG standards for infants and children. Pediatr Cardiol 1979;1:123-231.
15. Jaeggi ET, Fouran JC, Silverman ED, et al: Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004;110:1542-1548.
16. Copel JA, Buyon JP, Kleinman CS: Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995;173:1384-1390.
17. Costdoat-Chalumeau N, Amoura Z, Le Thi Hong D, et al: Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003;63:1010-1012.
18. Yeh TF, Lin YJ, Lin HC, et al: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
19. Brucato A, Frassi M, Franceschini F, et al: Risk of congenital heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-1835.
20. Van Bergen AH, Cuneo BF, Davis N: Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren's antibodies. Am J Obstet Gynecol 2004;191:1014-1018.
21. McLeod KA, Rankin AC, Houston AB: 1:1 atrioventricular conduction in congenital complete heart block. Heart 1998;80:525-526.
22. Wren C: Ventricular preexcitation producing resolution of complete atrioventricular block. Heart 2000;83:102.
23. Stinstra J, Golbach E, VanLeeuwen P, et al: Multicenter study of fetal cardiac time intervals using magnetocardiography. BJOG 2002;109:1235-1243.
24. Rein AJJT, O'Donnell C, Geva T, et al: Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 2002;106:1827-1833.